Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
13 06 2019
13 06 2019
Historique:
received:
12
10
2018
accepted:
08
03
2019
pubmed:
10
4
2019
medline:
10
1
2020
entrez:
10
4
2019
Statut:
ppublish
Résumé
CD30 is expressed on a variety of B-cell lymphomas, such as Hodgkin lymphoma, primary effusion lymphoma, and a diffuse large B-cell lymphoma subgroup. In normal tissues, CD30 is expressed on some activated B and T lymphocytes. However, the physiological function of CD30 signaling and its contribution to the generation of CD30
Identifiants
pubmed: 30962205
pii: S0006-4971(20)42490-5
doi: 10.1182/blood.2018880138
doi:
Substances chimiques
Ki-1 Antigen
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2597-2609Informations de copyright
© 2019 by The American Society of Hematology.